5[No authors listed].Intensive blood-glucose control with sulphonylureas or insulin ompared with conventional treatment and risk of in patients with type 2 diabetes (UKPDS 33).UK Prospective Diabetes Study(UKPDS) Group [J].Lancet,1998,352(9131):837-853.
7Parving HH,Lehnert H,Brochner-Mortensen J,et al.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes [J].N Engl J Med,2001,345(12):870-878.
8Shahinfar S,Dickson TZ,Ahmed T,et al.Losartan in patients with type 2 diabetes and proteinuria:Observations from the RENAAL Study[J].Kidney Int Suppl,2002,(82):64-70.
9Rossing K,Jacobsen P,Pietraszek L,et al.Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy:a randomized double-blind crossover trial [J].Diabetes Care,2003,26(8):2268-2274.
